![]() |
市場調查報告書
商品編碼
1930083
全球腦健康補充品市場:市場規模、佔有率、成長率、產業分析、依類型、應用和地區劃分的考察以及未來預測(2026-2034)Brain Health Supplements Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034 |
||||||
隨著人們對認知健康、心理健康和與年齡相關的神經系統疾病的關注度不斷提高,全球腦健康補充品市場持續穩定成長。根據 Fortune Business Insights 預測,腦健康補充劑市場規模在2025年達到 67.4億美元,並預計將在2026年成長至 72.4億美元。在老年人和年輕人群體接受度不斷提高的推動下,該市場預計將在2026年至2034年間以 8.00%的年複合成長率成長,到2034年達到 136.9億美元。
北美在2025年佔據全球市場主導地位,市場佔有率為 48.86%,這主要得益於人們對認知障礙的高度關注、強大的購買力以及對用於心理健康的膳食補充劑的廣泛接受。
市場概覽
腦健康補充品是指目的是維持認知功能、記憶力、專注力和思考清晰度的補充品。這些補充劑通常含有維生素、礦物質、植物萃取物和促智成分,有助於維持大腦功能。人口老化、飲食相關慢性疾病盛行率上升以及認知障礙和阿茲海默症發病率增加是推動市場成長的關鍵因素。
此外,遵循限制性或特殊飲食的人群以及慢性病患者也日益選擇服用這些補充劑來維護整體大腦健康。
新冠疫情的影響
新冠疫情加速了人們對心理健康、壓力、焦慮和情緒健康的討論,對腦部健康補充劑市場產生了積極影響。疫情封鎖期間,人們面臨的心理健康挑戰日益增多,這提升了消費者對支持認知功能和情緒平衡的補充劑的興趣。此外,疫情也促使人們更加重視預防保健和生活品質,推動了對腦部健康補充劑的需求。
在此期間,策略行銷活動以及與心理健康支援組織的合作進一步提高了產品的知名度。
腦健康補充品市場趨勢
新型膳食成分的引進
製造商正致力於引進新的、經科學驗證的營養成分,以增強腦健康補充劑的安全性和有效性。新成分獲得監管部門批准,有助於企業拓展產品組合,並增強消費者信任。
例如,2023年8月,AKER BIOMARINE的營養成分 "LYSOVETA" 獲得美國FDA批准,有助於改善與年齡相關的認知衰退。此類批准在推動市場創新和普及方面發揮著重要作用。
市場成長因素
產品組合的拓展與新進者的湧入
年輕人心理健康意識的提高減少對認知障礙的歧視,並促進積極的健康管理。這種轉變推動新進業者、自有品牌製造商和投資者進入市場。對含有天然成分的膳食補充劑的需求進一步加速了市場准入。
此外,代工生產的廣泛普及也使得新興品牌更容易以具有競爭力的價格推出腦部健康補充品產品。
運動產業的日益普及
體育產業正逐漸成為腦部健康補充品的重要消費族群。運動員越來越意識到營養在提高專注力、反應速度和心理耐力方面的重要作用。運動營養產品添加促智成分,以支持認知能力和整體運動表現。
補充劑生產商與體育組織之間的合作也進一步推動了市場需求。
限制因子
儘管需求不斷成長,但市場仍面臨諸多挑戰,例如產品成本高、部分補充劑缺乏臨床證據以及消費者和醫療專業人員的認知度較低。對副作用的擔憂、使用未經批准的成分以及標籤不一致等問題也限制了它們在某些地區的普及。
此外,低收入國家缺乏經濟能力也是市場滲透的障礙。
依產品類型
依產品類型劃分,市場分為益智補充劑和維生素及礦物質補充劑。
預計到2026年,維生素及礦物質補充劑將佔據79.05%的市場佔有率,這主要得益於其在所有年齡層中的受歡迎程度以及消費者對必需營養素的強烈信任。
由於對認知增強產品的需求不斷成長,預計益智補充劑將實現最快的成長速度。
依劑型
依劑型劃分,市場包括錠劑、膠囊和其他劑型。
2026年,膠囊劑型將佔據市場主導地位,市場佔有率高達69.40%,這主要得益於其服用方便、清潔標籤的吸引力以及配方的靈活性。
依應用領域劃分
依應用領域劃分,市場可分為認知功能、壓力/焦慮及其他領域。
2026年,壓力/焦慮領域將以45.43%的市場佔有率領跑,反映出全球心理壓力水準的上升。
依通路劃分
醫院藥局、藥局/零售藥局、線上通路和其他通路構成了分銷結構。
2026年,醫院藥局將佔據43.75%的市場佔有率,但由於線上通路的便利性和可近性,預計將快速成長。
北美地區在2025年和2026年仍將保持領先地位,這主要得益於神經系統疾病的高診斷率和消費者對營養補充劑的強勁支出。
歐洲地區將以技術進步和認知功能監測工具維持較大的市場佔有率。
亞太地區預計將強勁成長,這主要得益於電子商務平台的擴張和新興經濟體消費者意識的提高。
The global brain health supplements market is gaining steady momentum as awareness of cognitive health, mental wellness, and age-related neurological conditions continues to rise worldwide. According to Fortune Business Insights, the brain health supplements market was valued at USD 6.74 billion in 2025 and is projected to grow to USD 7.24 billion in 2026. Supported by increasing adoption among aging populations and younger consumers alike, the market is forecast to reach USD 13.69 billion by 2034, expanding at a CAGR of 8.00% during the 2026-2034 forecast period.
North America dominated the global market with a 48.86% share in 2025, driven by high awareness of cognitive disorders, strong purchasing power, and widespread acceptance of dietary supplements for mental wellness.
Market Overview
Brain health supplements are dietary products designed to support cognitive function, memory, focus, and mental clarity. These supplements typically contain vitamins, minerals, botanical extracts, and nootropic ingredients that assist in maintaining brain performance. The rising aging population, increasing prevalence of diet-related chronic diseases, and growing incidence of cognitive impairment and Alzheimer's disease are major factors supporting market growth.
In addition, individuals following restricted or specialized diets and people managing chronic medical conditions are increasingly adopting these supplements to support overall brain health.
Impact of COVID-19
The COVID-19 pandemic positively impacted the brain health supplements market by accelerating conversations around mental health, stress, anxiety, and emotional well-being. Increased exposure to mental health challenges during lockdowns led to higher consumer interest in supplements supporting cognitive performance and mood balance. Moreover, the pandemic encouraged individuals to prioritize preventive healthcare and quality of life, boosting demand for brain health supplements.
Strategic marketing campaigns and collaborations with mental health advocates further enhanced product visibility during this period.
Brain Health Supplements Market Trends
Introduction of New Dietary Ingredients
Manufacturers are increasingly focusing on introducing novel, scientifically backed dietary ingredients to improve the safety and efficacy of brain health supplements. Regulatory approvals for new ingredients are enabling companies to expand their product portfolios and strengthen consumer trust.
For instance, in August 2023, AKER BIOMARINE received U.S. FDA approval for LYSOVETA, a dietary ingredient designed to support cognitive decline during aging. Such approvals play a critical role in driving innovation and adoption in the market.
Market Growth Factors
Expansion of Product Portfolios and New Market Entrants
Growing awareness of mental health among younger populations has reduced stigma around cognitive disorders and encouraged proactive health management. This shift has attracted new entrants, private-label manufacturers, and investors into the market. Demand for supplements containing naturally sourced ingredients is further accelerating market entry.
In addition, the availability of contract manufacturing services has made it easier for emerging brands to launch brain health supplement products at competitive prices.
Rising Adoption in the Sports Industry
The sports industry is emerging as an important consumer segment for brain health supplements. Athletes increasingly recognize the role of nutrition in enhancing focus, reaction time, and mental endurance. Nootropic ingredients are being incorporated into sports nutrition products to support cognitive performance and overall athletic outcomes.
Collaborations between supplement manufacturers and sports organizations are further supporting market demand.
Restraining Factors
Despite growing demand, the market faces challenges such as high product costs, limited clinical evidence for some supplements, and lack of awareness among consumers and healthcare professionals. Concerns regarding side effects, unapproved ingredients, and inconsistent labeling also restrict adoption in certain regions.
Additionally, limited affordability in low-income countries acts as a barrier to widespread market penetration.
By Product Type
The market is segmented into nootropic supplements and vitamins & minerals.
The vitamins & minerals segment accounted for a dominant 79.05% market share in 2026, driven by widespread use across all age groups and strong consumer trust in essential nutrients.
Nootropic supplements are projected to grow at the fastest rate due to increasing demand for cognitive enhancement products.
By Dosage Form
Based on dosage form, the market includes tablets, capsules, and others.
The capsules segment dominated with a 69.40% share in 2026, supported by ease of consumption, clean-label appeal, and formulation flexibility.
By Application
The market is segmented into cognitive function, stress & anxiety, and others.
The stress & anxiety segment led the market with a 45.43% share in 2026, reflecting rising mental stress levels globally.
By Distribution Channel
Hospital pharmacies, drug stores & retail pharmacies, online channels, and others form the distribution landscape.
Hospital pharmacies accounted for a 43.75% share in 2026, while online channels are expected to grow rapidly due to convenience and accessibility.
North America remained the leading region in 2025 and 2026, supported by high diagnosis rates of neurological disorders and strong consumer spending on supplements.
Europe held a substantial share due to technological advancements and cognitive monitoring tools.
Asia Pacific is expected to witness strong growth driven by expanding e-commerce platforms and rising awareness in emerging economies.
Competitive Landscape
The market is fragmented, with companies focusing on new product launches, collaborations, and brand expansion. Key players include Reckitt Benckiser Group PLC, Natrol LLC, Neurohacker Collective, Onnit Labs, and Natural Factors USA, among others.
Conclusion
The global brain health supplements market, valued at USD 6.74 billion in 2025, increased to USD 7.24 billion in 2026 and is projected to reach USD 13.69 billion by 2034. Market growth is supported by rising awareness of cognitive health, increasing adoption across age groups, product innovation, and expanding distribution channels.
Segmentation By Product Type
By Dosage Form
By Application
By Distribution Channel
By Region